Indoco Remedies Stock Screener | Share Price & Fundamental Analysis
INDOCO
Pharmaceuticals
Share Price NSE
₹198.22
▲
5.34 (2.77%)
Share Price BSE
₹197.15
▲
3.35 (1.73%)
Track Indoco Remedies share price live with TickJournal's free stock screener.
Analyze Indoco Remedies share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Indoco Remedies Market Cap
₹1,728.66 Cr.
INDOCO P/E Ratio (TTM)
-14.75
Indoco Remedies P/B Ratio
1.75
EPS (TTM)
₹-8.46
Dividend Yield
0.11%
Debt to Equity
0.78
INDOCO 52 Week High
₹339.10
Indoco Remedies 52 Week Low
₹164.00
Operating Margin
-2.00%
Profit Margin
-10.62%
INDOCO Revenue (TTM)
₹386.00
EBITDA
₹-5.00
Net Income
₹-41.00
Total Assets
₹2,430.00
Total Equity
₹1,018.00
Indoco Remedies Share Price History - Stock Screener Chart
Screen INDOCO historical share price movements with interactive charts. Analyze price trends and patterns.
Indoco Remedies Company Profile - Fundamental Screener
Screen Indoco Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INDOCO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE873D01024
Indoco Remedies Balance Sheet Screener
Screen INDOCO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 2,430 | 2,145 | 1,658 | 1,486 | 1,315 | 1,272 | 1,258 | 1,236 | 1,197 | 941 |
| Current Assets | 1,001 | 955 | 814 | 774 | 623 | 563 | 538 | 537 | 572 | 465 |
| Fixed Assets | 997 | 954 | 678 | 555 | 570 | 590 | 468 | 489 | 440 | 374 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 604 | 422 | 205 | 157 | 139 | 133 | 152 | 146 | 155 | 61 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,018 | 1,111 | 1,028 | 905 | 769 | 680 | 661 | 675 | 651 | 577 |
| Share Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Reserves & Surplus | 1,004 | 1,092 | 1,010 | 886 | 751 | 661 | 642 | 657 | 633 | 558 |
Indoco Remedies Income Statement Screener - Profit & Revenue Analysis
Screen Indoco Remedies income statement and profit fundamentals.
Analyze INDOCO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Indoco Remedies share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 386 | 433 | 473 | 435 | 462 | 425 | 432 | 404 | 429 | 417 | 478 | 461 | 401 | 396 | 405 |
| Expenses | 391 | 422 | 442 | 420 | 401 | 384 | 392 | 399 | 363 | 365 | 410 | 405 | 329 | 337 | 345 |
| EBITDA | -5 | 10 | 30 | 15 | 61 | 42 | 40 | 6 | 66 | 52 | 68 | 56 | 72 | 60 | 60 |
| Operating Profit % | -2.00% | 2.00% | 6.00% | 3.00% | 9.00% | 10.00% | 9.00% | 1.00% | 15.00% | 12.00% | 13.00% | 12.00% | 18.00% | 15.00% | 15.00% |
| Depreciation | 29 | 30 | 32 | 32 | 26 | 28 | 29 | 29 | 18 | 20 | 21 | 24 | 18 | 20 | 16 |
| Interest | 18 | 26 | 25 | 26 | 12 | 14 | 18 | 16 | 9 | 8 | 8 | 10 | 3 | 4 | 5 |
| Profit Before Tax | -46 | -37 | -14 | -31 | 33 | 7 | -5 | -31 | 39 | 34 | 46 | 23 | 60 | 48 | 67 |
| Tax | -4 | 0 | -4 | -2 | 11 | 5 | 5 | -3 | 13 | 10 | 11 | 7 | 19 | 10 | 18 |
| Net Profit | -41 | -36 | -9 | -30 | 22 | 2 | -10 | -28 | 26 | 24 | 35 | 16 | 41 | 39 | 50 |
| EPS | -4.48 | -3.94 | -1.00 | -3.20 | 2.39 | 0.20 | -1.09 | -3.08 | 2.80 | 2.62 | 3.82 | 1.69 | 4.39 | 4.19 | 5.40 |
Indoco Remedies Cash Flow Screener - Liquidity Fundamentals
Screen INDOCO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 95 | 155 | 179 | 174 | 82 | 123 | 132 | 123 | 89 | 112 |
| Investing Activities | -339 | -432 | -208 | -121 | -67 | -56 | -104 | -135 | -171 | -111 |
| Financing Activities | 241 | 280 | 23 | -44 | -30 | -64 | -16 | -39 | 132 | -2 |
| Net Cash Flow | -3 | 4 | -7 | 8 | -14 | 3 | 12 | -52 | 50 | 0 |
Indoco Remedies Shareholding Pattern Screener
See Indoco Remedies shareholding pattern with promoter, FII, and DII holdings.
Check Indoco Remedies promoter holding and ownership changes for INDOCO on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 58.90% | 58.90% | 58.90% | 58.90% | 58.72% | 58.75% | 58.75% | 58.80% |
| FII Holding | 1.24% | 1.22% | 1.25% | 1.10% | 1.91% | 1.47% | 1.70% | 1.25% |
| DII Holding | 18.75% | 18.96% | 18.16% | 18.15% | 19.41% | 18.67% | 18.24% | 18.90% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.99% | 15.79% | 16.40% | 16.48% | 15.33% | 16.29% | 16.30% | 16.07% |
| Other Holding | 5.12% | 5.14% | 5.29% | 5.38% | 4.62% | 4.81% | 5.01% | 4.99% |
| Shareholder Count | 34,497 | 33,129 | 33,319 | 32,659 | 33,201 | 34,511 | 34,416 | 34,676 |
Indoco Remedies Share Dividend Screener - Share Yield Analysis
Check Indoco Remedies dividend history with payout and yield data.
View Indoco Remedies dividend details including ex-dates and amounts for INDOCO stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.20 | 0.12% |
| 2024-March | ₹1.50 | 0.64% |
| 2023-March | ₹2.25 | 0.68% |
| 2022-March | ₹2.25 | 0.69% |
| 2021-March | ₹1.50 | 0.40% |
| 2020-March | ₹0.30 | 0.10% |
| 2019-March | ₹0.30 | 0.14% |
| 2018-March | ₹1.00 | 0.49% |
| 2017-March | ₹1.60 | 0.75% |
Indoco Remedies Stock Index Membership
See which indices include Indoco Remedies stock.
Check INDOCO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Indoco Remedies Market Events Screener - Corporate Actions
Get Indoco Remedies corporate actions including splits, bonuses, and buybacks.
Check Indoco Remedies stock events that may affect INDOCO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.20 /share | 8.04% | ||
| Dividend | ₹ 0.75 /share | 8.37% | ||
| Dividend | ₹ 1.50 /share | 10.13% | ||
| Dividend | ₹ 2.25 /share | 2.59% | ||
| Dividend | ₹ 1.50 /share | 12.85% | ||
| Annual General Meeting | NA | 0.00% | ||
| Dividend | ₹ 1.50 /share | 31.90% | ||
| Annual General Meeting | NA | -5.74% | ||
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | 0.46% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | -7.97% |
| 2025-07-24 | 2025-07-24 | Quarterly Result Announcement | NA | -4.86% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 4.17% |
| 2025-01-21 | 2025-01-21 | Quarterly Result Announcement | NA | 2.60% |
| 2024-10-24 | 2024-10-24 | Quarterly Result Announcement | NA | -4.96% |
Indoco Remedies Competitors Screener - Peer Comparison
Screen INDOCO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.86 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 63.26 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 61.20 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,954 | 22.26 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.27 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.31 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.29 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.81 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.37 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.87 | 13,458 | 3.70% | 2,216 | 42.54 |
Indoco Remedies Company Announcements - News Screener
Screen INDOCO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-05 | Announcement Under Regulation 30 Of SEBI LODR-- Intimation Of Re-Appointment Of Cost Auditor And Internal Auditor Of The Company | - |
| 2026-04-04 | Closure of Trading Window | - |
| 2026-03-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-09 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-03 | Financial Results For The Quarter And Nine Months Ended 31St December 2025 | - |
| 2026-02-03 | Board Meeting Outcome for Outcome Of Board Meeting Held On 03/02/2026 | - |
| 2026-02-03 | Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-16 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-01-13 | Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-31 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-31 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-12-30 | Closure of Trading Window | - |